HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.

60 Clinical Trials
Lymphoma Phase I Accepting Patients
nct/study# NCT04663347 / GCT3013-02

A Phase 1b/2, Open-Label Trial To Assess The Safety And Preliminary Efficacy Of Epcoritamab (GEN3013; Duobody®-CD3xCD20) In Combination With Other Agents In Subjects With B-Cell Non-Hodgkin Lymphoma

Learn More
Lymphoma Phase I Active
nct/study# NA / CA097-001

A Phase 1, Multicenter, Open-Label Study Of Bms-986403 In Subjects With Relapsed And/Or Refractory Chronic Lymphocytic Leukemia (Cll) Or Small Lymphocytic Lymphoma (Sll)

Learn More
Lymphoma Phase I/II Accepting Patients
nct/study# NCT04623541 / GCT3013-03

A Phase 1b/2, Open-Label, Safety And Efficacy Study Of Epcoritamab (GEN3013; Duobody®-CD3 X CD20) In Relapsed/Refractory Chronic Lymphocytic Leukemia

Learn More
Lymphoma NA Active
nct/study# NA / KT-US-982-5968

Long-Term Follow-Up Study For Participants Of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Learn More
Lymphoma Phase I/II Accepting Patients
nct/study# NCT02956382 / PRO2016-0014-C103287

Ibrutinib And Venetoclax In Relapsed And Refractory Follicular Lymphoma

Learn More
Lymphoma Phase II Accepting Patients
nct/study# NCT03467867 / PRO2018-0577

A Phase II Study Of Venetoclax And Rituximab/Hyaluronidase Human In Relapsed/Refractory CLL

Learn More

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.